文献速递传染病防控与疫情报告营养与食品安全卫生政策与健康促进

捷克共和国人类沙门氏菌病流行病学:欧洲报告率最高国家2012至2023年分析

Epidemiology of human salmonellosis in Czechia ─ a country with the highest European notification rate, 2012 to 2023.
PubMed 文献 · Euro Surveill · 2026-01-01

该研究基于国家监测系统分析捷克2012至2023年沙门氏菌病通报病例,共130,990例,总通报率为102.7/10万。年通报率从2012-2017年的111.7/10万降至2018-2023年的94.2/10万,但仍处高位;仅45.6%病例明确传播途径,超过半数来源不明。

要点

  • 捷克沙门氏菌病通报率虽下降但仍为欧洲最高之一,2012-2023年共130,990例。
  • 52.2%病例为15岁以下儿童青少年,6-10月为发病高峰(63.4%)。
  • 仅2.0%为输入性病例,4.1%与暴发相关,45.6%明确传播途径。

核心结论

  • 尽管通报率下降,捷克沙门氏菌病通报率仍居高不下。
  • 监测系统有效性体现为住院率相对较低,但过半病例来源和传播途径未明。
  • 建议加强流行病学调查、提高样本送检国家参考实验室及分子监测。

研究设计与样本

  • 基于国家监测系统的描述性研究,提取2012-2023年通报的沙门氏菌病病例数据。
  • 分析人口学特征、住院、传播模式及疑似传播载体,采用卡方检验和逻辑回归。

主要发现

  • 2012-2023年共通报130,990例,总通报率102.7/10万。
  • 年通报率从2012-2017年的111.7/10万降至2018-2023年的94.2/10万。
  • 15岁以下儿童青少年占52.2%(68,370例),女性占52.2%(68,425例),但15岁以下男性占多数(35,790/68,370;52.3%)。
  • 输入性病例2,627例(2.0%),暴发相关5,361例(4.1%),6-10月诊断83,057例(63.4%)。
  • 住院29,082例(22.2%);年龄≥40岁与住院及沙门氏菌败血症相关(p<0.001)。

临床怎么用

  • 应强化沙门氏菌病流行病学调查,尤其针对来源不明病例。
  • 提高临床样本送检国家参考实验室的比例,以改善病原确认。
  • 推进分子监测以识别传播链和暴发源头。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUNDSalmonellosis is the second most notified food-borne infection in Europe. In Czechia (CZ), the notification rate has consistently been above the European average, five times higher in 2013-2022.AIMWe aimed to describe the epidemiology of salmonellosis in CZ in 2012-2023 and identify areas for improving surveillance and public health actions.METHODSWe extracted data on notified salmonellosis cases from the national surveillance system and analysed the dataset for demographic characteristics, hospitalisation, transmission mode and suspected vehicle, descriptively and by chi-square tests and logistic regression.RESULTSIn 2012-2023, 130,990 cases (102.7/100,000 inhabitants) were notified. The overall annual notification rate decreased from 111.7 per 100,000 in 2012-2017 to 94.2 per 100,000 in 2018-2023. Most cases were children and adolescents aged < 15 years (n = 68,370; 52.2%) and most were females (n = 68,425; 52.2%) but males dominated among cases aged < 15 years (35,790/68,370; 52.3%). Few cases were imported (n = 2,627; 2.0%) or outbreak-related (n = 5,361; 4.1%); most were diagnosed in June-October (n = 83,057; 63.4%). Of all notified cases, 22.2% (n = 29,082) were hospitalised. Age of ≥ 40 years was associated with hospitalisation and Salmonella sepsis (p < 0.001). Transmission mode was identified for 59,729 (45.6%) cases.CONCLUSIONDespite a decline, the notification rates of salmonellosis remain high in CZ. The effectiveness of the surveillance system is reflected in relatively low hospitalisation rates compared with some other European countries, yet the source and transmission mode were unidentified in over half of the cases. We encourage enhancing epidemiological investigations, improving sample submission to the National Reference Laboratory and molecular surveillance.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Špačková M, Liptáková M, Daniel O, et al. Epidemiology of human salmonellosis in Czechia ─ a country with the highest European notification rate, 2012 to 2023. Euro Surveill. 2026. PMID: 41572899. doi:10.2807/1560-7917.ES.2026.31.3.2500223

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。